Cite
MLA Citation
J. E. Gehin et al.. “SAT0185 Certolizumab pegol serum levels ≥20 mg/l are associated with improvement in das28 in rheumatoid arthritis patients. data from the nor-dmard study.” Annals of the rheumatic diseases, vol. 77, n.d., pp. 953–954. http://access.bl.uk/ark:/81055/vdc_100144710632.0x00004d